Clinical Microbiology and Infection

Slides:



Advertisements
Similar presentations
Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10.
Advertisements

Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity  Francesca Colavita, Serena Quartu, Eleonora Lalle, Licia Bordi, Daniele.
Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10.
R. Cavallo  Clinical Microbiology and Infection 
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
Cryptococcosis—the impact of delay to diagnosis
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Virus Infections Immunity
Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein–Barr virus serologic.
Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real- time PCR findings in apparently immunocompetent patients: a case.
Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines.
Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.
Hepatitis in the traveller
Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:
Figure Seropositivity for IgG against HSV-1, CMV, and EBV
HIV Increases HCV Replication in a TGF-β1–Dependent Manner
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation—an insight from.
Migration and infectious diseases
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care  S. Chevaliez,
Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections.
Infectious Disease Following Kidney Transplant: Core Curriculum 2010
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004–2011 in Guangzhou, China  Y.-F. Wang, H.-F. Xu, Z.-G.
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice  J.
G. Zhao, H. Zhai, Q. Yuan, S. Sun, T. Liu, L. Xie 
Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein--Barr viraemia  T. Martelius, V.-J. Anttila  Clinical.
B. Edvinsson, M. Lappalainen, B. Evengård 
Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations  R. Ashley-Morrow,
Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection  Y.W.
Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:
J. Zhang, X. -F. Zhang, C. Zhou, Z. -Z. Wang, S. -J. Huang, X. Yao, Z
E. Galmozzi, F. Facchetti, R. Perbellini, A. Aghemo 
F. Li, P. Zhou, W. Deng, J. Wang, R. Mao, Y. Zhang, J. Li, J. Yu, F
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon.
A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen- positive patients: a prospective cohort study in China  Y. Zhang,
Liver is liver and blood is blood, and finally the twain have met
B.F.C. Sampaio, M.S. Macre, L.R. Meireles, H.F. Andrade 
Serological responses to Cryptosporidium in human populations living in areas reporting high and low incidences of symptomatic cryptosporidiosis  K. Elwin,
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Chagas disease in the immunosuppressed patient
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients.
C.G. Teo  Clinical Microbiology and Infection 
Cells with CD4 receptor on surface
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus.
Prospective evaluation of a dot-blot enzyme immunoassay (Directigen RSV) for the antigenic detection of respiratory syncytial virus from nasopharyngeal.
European quality clearance of new microbiological diagnostics
Hepatitis B and C virus-related carcinogenesis
Voriconazole concentrations and outcome of invasive fungal infections
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae  I. Gustafsson, O. Cars  Clinical Microbiology.
Thermal and pH stability of influenza viruses.
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm  F. Gouriet,
Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells  D. Lilleri,
Survival of rhinoviruses on human fingers
Treatment of infants coinfected with HIV-1 and cytomegalovirus with combination antiretrovirals and ganciclovir  Akihiko Saitoh, Rolando M. Viani, Rachel.
Fertility and Sterility
The burden of chikungunya in the Pacific
Timeline of common infections in transplant recipients.
Presentation transcript:

Clinical Microbiology and Infection Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections  M.M. Remy, M. Alfter, M.-N. Chiem, M.T. Barbani, O.B. Engler, F. Suter-Riniker  Clinical Microbiology and Infection  DOI: 10.1016/j.cmi.2018.10.016 Copyright © 2018 The Authors Terms and Conditions

Clinical Microbiology and Infection DOI: (10.1016/j.cmi.2018.10.016) Copyright © 2018 The Authors Terms and Conditions

Fig. 1 Agreement of serological test results after chemical or thermal inactivation of patient serum samples. Bland–Altman plots showing differences versus average of treated and control samples in percent (bias). Patient serum samples inactivated with Triton X-100 0.1% (a), Triton X-100 1% (b), heat inactivation at 60°C for 1 h (c), or a combination of Triton X-100 0.1% and heat inactivation (d) were used for a panel of ELISA-based serological assays including automated chemiluminescence immunoassays (CMIA and CLIA) and manual ELISAs (Man.) Control samples received an equivalent amount of PBS. Solid lines indicate mean bias, dashed lines indicate 95% limits of agreement (mean ± 1.96 SD), dotted lines indicate 0 (no bias). Abbreviations: HIV, human immunodeficiency virus; HCV, hepatitis C virus; HBV, hepatitis B virus; EBV, Epstein-Barr virus; CMV, human cytomegalovirus; Toxo, Toxoplasma gondii; DENV, Dengue virus; Ag, antigen; Ab, antibody. Clinical Microbiology and Infection DOI: (10.1016/j.cmi.2018.10.016) Copyright © 2018 The Authors Terms and Conditions

Fig. 2 Influence of serum concentration on the chemical inactivation of herpes simplex virus type 1 (HSV-1). Reduction in HSV-1 titres in samples containing either 1% fetal bovine serum (FBS) or 90% human serum after treatment with 0.1% or 1% Triton X-100 for 1 h at room temperature. Controls received an equivalent amount of PBS. Before titration, samples were filtrated through 100-kDa membranes to remove residual Triton X-100. Unfiltered PBS controls are shown to account for eventual virus loss through the filter. TCID50/ml titres presented as mean ± SD were determined in three independent experiments with 4-8 replicates per experiment. Abbreviations: HSV-1, herpes simplex virus type 1; TCID50, 50% Tissue Culture Infectious Dose. Clinical Microbiology and Infection DOI: (10.1016/j.cmi.2018.10.016) Copyright © 2018 The Authors Terms and Conditions